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Abstract

The biopharmaceutical industry is regarded as a knowledge industry. However, in general,
the industry is not effective at managing its knowledge as an asset across the product lifecycle,
including during fundamental processes such as technology transfer. This is true in particular
for tacit knowledge (e.g., know-how), where tacit knowledge it considered critical to the
success of technology transfer, yet tacit knowledge transfer is somewhat ineffective. This can
lead to the introduction of risk and other undesirable outcomes. This paper profiles a case
study in tacit knowledge flow where a series of pragmatic practices were deployed during a
complex vaccine drug substance technology transfer. These practices demonstrated
improvements in tacit knowledge flow as evidenced by learning, process improvements and
gaps in knowledge identified, which were subsequently addressed to reduce risk, increase
product and process understanding, improve robustness, and define future development
needs. Common success factors for these simple practices are explored through the case
study. A key takeaway is that such knowledge transfer processes do not need to be complex
nor onerous in order to achieve tangible improvements in knowledge transfer effectiveness.

1. Introduction

The biopharmaceutical industry is a knowledge industry with its intensive use of technology
and human capital [1]. Indeed a biopharmaceutical company’s long-term viability flows from
its ability to develop, apply and grow knowledge about products and processes while ensuring
sufficient supply of safe, efficacious and cost-effective products to the marketplace. Thus,
knowledge is an asset to the company and as such, there is value in managing knowledge
assets in the same way as physical assets [2].
Standard Knowledge Management (KM) practices 1 can be used as a means to improve the
effectiveness of how knowledge is managed as an asset and how knowledge flows through
an organization [3]. Ideally, for a biopharmaceutical product, knowledge must flow across
the entire lifecycle from product development through to product discontinuation [4]. Yet
research has shown that the current effectiveness of knowledge management in the
biopharmaceutical industry is lacking [2]. Knowledge is not managed as an asset, does not
flow freely, and ‘leaks’ from the organization through a variety of means, including [5], [6]:
The term ‘practice’ refers to the collective approach or methodology used, typically consisting of
considerations for people (e.g., roles and mindsets), process, technology and governance
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employee turnover
inconsistent expectations and processes for knowledge capture
sub-optimal capture and use of lessons learned
organizational ‘silos’
ineffective knowledge transfer between people and/or functional groups)

This ‘leakage’ is especially true given the long cycle times associated with the
biopharmaceutical product lifecycle, large number of people involved, highly complex
processes, and typically global distributed nature of research, manufacturing, and supply
chain organizations.
A recent study by the authors on the importance of knowledge transfer for the sustained
success of technology transfer found that the transfer of explicit knowledge (e.g. documents)
and tacit knowledge (e.g. ‘know-how’) were both extremely important to successful
technology transfer. However in gauging knowledge transfer effectiveness, the transfer of
explicit knowledge was found to be only marginally effective. The transfer of tacit knowledge
fared worse, as it was considered somewhat ineffective [5].
This paper presents a brief introduction to tacit knowledge as related to the
biopharmaceutical industry and its importance to technology transfer. This is followed by a
case study profiling a series of practices to facilitate tacit knowledge transfer during a new
product introduction technology transfer, along with the results achieved.

2. ‘Tacit knowledge’ and its importance

Some definitions of tacit knowledge refer to philosophical or abstract concepts. A common
example is the knowledge of how to ride a bike. How do you know this, and how would you
describe this to someone else? Polanyi is credited with the term tacit knowledge in his 1966
book, the Tacit Dimension, and the related observation that “we know more than we can tell.”
[7]
Tacit knowledge can be defined as skills, ideas and experiences that people have but are not
codified and may not necessarily be easily expressed [8]. With tacit knowledge, people are
not often aware of the knowledge they possess or how it can be valuable to others. Effective
transfer of tacit knowledge generally requires extensive personal contact, regular interaction,
and trust [9]. A tangible example of this is the journeyman and apprentice, where the
apprentice is coached over an extended period by the highly skilled and experienced
journeyman. In fact, 70% to 80% of the collective knowledge in biopharmaceutical companies
is tacit knowledge [10], [11] yet these assets are not managed well.
In contrast to explicit knowledge, which is commonly regarded as know-what (i.e., facts), tacit
knowledge can be described as know-how. In the limited references to tacit knowledge
currently embedded in biopharmaceutical literature, know-how is the most common
expression representing tacit knowledge, along with related concepts of experienced and
expert [4], [12]–[15].
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In addition, the concepts of know-why and know-who can also be considered tacit knowledge
[16], and the authors find the illustration in Figure 1 by shared Brinson [17] useful to depict
this visually by linking knowledge to actions. In particular, the inner relationships of insight
(know-what + know-why), reaction (know-why + know-how) and method (know-what +
know-how) are of clear and inherent value to knowledge work of the biopharmaceutical
industry in pursuit of meaningful action as found in the centre of the figure.

Figure 1 – Know-What, Know-Why and Know-How [17]

Knowing what, why and how empowers the decision maker with the best available knowledge
on hand, to take the most meaningful actions to manage risk to both the patient and the
business. Ensuring this knowledge is available and is applied is key as demonstrated in the
Risk-Knowledge Infinity Cycle described in 2020 by Lipa et al [18]. This framework (Figure 2)
highlights the relationship between knowledge and risk: As knowledge increases, risk
decreases. This is accomplished in part by ensuring the effective flow of knowledge in-to and
out-of risk management and other business processes.

Figure 2 - The Risk-Knowledge Infinity Cycle [18]
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3. Tacit knowledge and technology transfer

This paper focuses on a biopharmaceutical product technology transfer and describes
pragmatic practices to enable the capture and transfer of tacit knowledge (i.e., technical
know-how and know-why, and to a lesser extent know-who). This case study demonstrates
how relatively simple practices can have a strong impact on how knowledge is managed as an
asset and in turn reduces risk to the patient.
The bias toward explicit knowledge and general neglect of tacit knowledge is perhaps not
surprising in an industry with the informal mantra “if it isn’t written down, it didn’t happen”,
as often reinforced by GMP (Good Manufacturing Practice) training. Yet, critical tacit
knowledge is expected to be transferred during technology transfer by industry experts and
regulatory agencies alike, including key development activities, learnings from failures, pilot
scale knowledge, how to run a process in a particular piece of equipment, how risk is
communicated, etc. [5].
According to APQC, “knowledge is sticky, and without a process it will not flow” [11]. There
are a variety of common knowledge management practices which can facilitate the structured
transfer of tacit knowledge, including:
•
•
•
•
•
•

social networks
storytelling
shadowing of experts
lessons learned / after action review
communities of practice
and others

However, these practices are not commonly employed during technology transfer within the
biopharmaceutical sector. Instead, typically there are unstructured practices used to transfer
tacit knowledge in a highly ad hoc manner. For example, where a receiving site representative
may observe a batch being manufactured at the sending site prior to transfer. Facility fits,
process walkthroughs and risk assessments are other means where some tacit knowledge is
transferred, although typically in an ad hoc manner.
The following case study presents examples of three structured KM practices which were
shown to be effective in enabling tacit knowledge flow during a new product introduction.

4. Case Study: Three (3) practices to improve tacit knowledge flow during
technology transfer

Recognizing the importance of tacit knowledge and the general ineffectiveness of tacit
knowledge transfer, an effort was undertaken during a technology transfer at a major multinational biopharmaceutical company to improve tacit knowledge transfer in support of ontime filing and commercial launch of a new therapy. It is important to note the case study
example is a highly complex vaccine drug substance product which resulted in a large number
of process performance qualification (PPQ) batches (i.e., there were a large number of
validation batches, many more than the typical 3). The transfer was a new product
introduction from a late-stage development organization to the full-scale commercial
manufacturing facility within the innovator company. Due to typical aggressive technology
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transfer timescales and resource constraints, the tactics for tacit knowledge capture and
transfer had to be as pragmatic as possible for the technology transfer team.
Drawing on best practices in knowledge management, each of the tacit knowledge transfer
practices reviewed in this case study share common elements, including:
•

•
•

Standardized business process for knowledge capture and transfer (and codification to explicit
knowledge, where appropriate)
Basic governance to ensure prioritization and follow through on important actions
Enabling mindsets for sending and receiving site personnel, including ‘safe to share’ and a
sense of inquisitiveness. This included active engagement and participation from people,
including experts from the sending site and members from the receiving site

In addition, each practice featured a targeted set of open-ended questions to foster dialogue,
tailored to the context at hand.
The three practices developed and utilized in this case study were:
1. What if…?
2. Technology Transfer Batch Execution Review
3. Tacit Knowledge Turnover Assessment

4.1.

What If…?

Process overview
The What if…? practice for knowledge transfer is a form of a risk assessment [19].
In this case study using What if…?, the technology transfer team took a stepwise approach to
interrogate the process in a structured manner by asking the sending site subject matter
expert (SME):
“What if <operating parameter x> exceeds it’s typical range?”
This was followed by a discussion on what evidence existed to support this knowledge. This
process explored what would happen at the typical high and low range limits and was
repeated for each operating parameter.
This practice was not intended to replace a formal quality risk assessment, but rather to
enhance dialogue amongst a broader team through a lens of discovering “what is known” and
“how do we know it?”. Figure 3 provides a process overview, including illustrative questions
asked as part of this process.
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Figure 3 – “What If...?" Process Overview

How the process helped with tacit knowledge transfer (“learn before”)
The What if…? practice, deployed by the receiving site-based technology transfer team,
created important dialogue between the SMEs of the sending site and the new process team
at the receiving site in exploring what is known about the performance of each operating
parameter at the boundary of its limits. This included the identification and transfer of
relevant supporting evidence (knowledge) which may not have been otherwise transferred.
This line of questioning also allowed the team to engage in rich discussion about ‘known
unknowns.’ In other words – known gaps in knowledge – such as areas not previously studied.
This enabled the receiving site to better understand risks, areas of uncertainty, process
sensitives, and inform future process development opportunities. The dialogue that
emerged created a powerful learning opportunity for the receiving site, enabling the team to
“learn before” process execution.
Results
In this case study, the What if… practice identified over 100 potential actions which were
grouped into key categories of:
•
•
•
•

Process knowledge (67%)
No data exists (16%)
Equipment knowledge (11%)
Other (6%)

Of these, a vast majority (84%) were actioned, indicating the site recognized the value in
addressing the gaps and closing them. A tracking mechanism with basic metrics and regular
review with the technology transfer leadership team (a governance body) were key enablers
to ensure this knowledge was acted upon and built back into the flow of the work.
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Technology Transfer Batch Execution Review

Process overview
For this technology transfer, the authors developed a new practice, named by the authors as
the Technology Transfer Batch Execution Review (TT-BER). TT-BER consists of two parts:
1. A pre-batch review, based on concepts found in a pre-job brief. A pre-job brief is a practice
often used in safety management processes involving high hazard and/or complex work
activities [20], [21]
2. A tailored After Action Review (AAR) [22], serving as a post-batch review

This pairing of reviews both before and after batch execution create a closed loop cycle
supporting risk mitigation, learning and continuous improvement.
In this case study, the technology transfer team huddled prior to execution of each PPQ batch
to conduct a pre-batch review. As part of this pre-batch review, the team reviewed key
questions including:
•
•
•

“What does good look like for our planned activity?”
“What changed since last time?”
“What is new, unique or difficult?”

An illustrative set of questions is included in Figure 4.
The back end of the TT-BER practice was the post-batch review. Practically speaking, this was
an after-action review tailored to the context of a batch execution. The technology transfer
team paused to reflect, drawing on after-action review best practices to explore a series of
key questions culminating with
•
•

“What can we learn?”
“Who needs to know?”

An illustrative set of after-action review questions is included in Figure 4.
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Figure 4 – Technology Transfer Batch Execution Review (TT-BER) Process

How the process helped with tacit knowledge transfer (“learn during”)
As discussed above, the TT-BER practice with pre-batch review and after action review
activities was newly conceived for this technology transfer project. The TT-BER ˆ provided a
powerful opportunity for the technology transfer team to come together and surface
assumptions, changes, areas of concern and other tacit knowledge held by the team members
in anticipating batch execution. Given this case study involved a new product introduction,
significant learning occurred involving the equipment and the process. In particular, the
context of the upcoming batch execution and what was known from the prior batch created
strong situational awareness for the team, enabling the team to better focus on successful
execution of the task at hand.
The TT-BER AAR (post-batch review) similarly provided a structured opportunity for the team
to pause and reflect on what actually happened versus what was intended to happen. The
open-ended questions on understanding why the actual outcome were not the same as
intended (whether for better or worse) and transforming this insight into an actionable
lesson. These insights drove tangible learning and improvement actions which were tracked
via the governance process. Through these reviews with associated dialogue, the TT-BER
process enabled the receiving site to “learn during” process execution in a very agile and
adaptive manner through the enhanced knowledge transfer.
Results
The metrics associated with the TT-BER practice are telling. The process produced 82
potential actions. Of these:
•

52 were implemented (63%)
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16 were tagged as future continuous improvement opportunities (20%)
11 were not applicable (e.g. duplicates, once-off, etc.) (13%)
3 were managed through the formal quality system (4%)

A qualitative review of the 52 actions implemented revealed that 43 of the 52 could have
potentially led to a deviation in the quality system had they not been proactively addressed.
For example, to conduct additional studies to extend hold times and thus mitigate future
deviations once the process execution cycle time and other logistics were better understood.
This demonstrated a powerful example of proactive risk mitigation and associated positive
impact to right-first-time execution, improved quality, reduced cost, and reduced lead time.
Furthermore, testimonials from the technology transfer team enthusiastically supported
these outcomes. The production area lead noted:
“the process enabled process improvement on a near real-time basis for items that
may have lingered for years. While items that were necessary to ensure ‘ready for
launch’ would have been captured, ‘ready for supply’ items may have been missed.”
This was a clear testament to the impact of TT-BER on the process robustness and future
manufacturability.
A further endorsement from the technology organization was as follows:
“After action review provided the required environment to generate an ambitious
continuous improvement recommendation to run small scale studies to extend the
proven acceptable range…not restricted by timeline & system. After action review
allowed time to ‘fix’ [potential issues].”
A tracking mechanism with basic metrics and regular review with the technology transfer
leadership team who provided appropriate governance were key enablers. This practice was
further recognized at the corporate manufacturing division by being awarded the winner of a
highly competitive award for innovation.

4.3.

Tacit Knowledge Turnover Assessment

Process overview
For this technology transfer, the authors developed a second new practice, named by the
authors as the Tacit Knowledge Turnover Assessment (TKTA). The authors intent was to
conceive a means to create further dialogue to reflect on understanding, uncertainty and risk
to augment the standardized post-campaign after action review. While the after action
review would focus on learning from the technology transfer and associated business process,
TKTA was intended to focus on product and process insights.
TKTA is a simple reflection process to evaluate the ‘big picture’ after PPQ batches were
complete but prior to attrition of the sending site subject matter experts (or their memories).
The sending site and receiving site selected their top 5 to 10 questions from a list of about 25
potential questions. Each group reflected on the questions independently and then met
9
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together to review as a team and agree on actions. Figure 5 provides a process overview and
illustrative questions used to prompt dialogue amongst the team.

Figure 5 – The Tacit Knowledge Turnover Assessment (TKTA) Process

How the process helped with tacit knowledge transfer (“learn after”)
As discussed above, the TKTA practice to capture tacit knowledge was newly conceived for
this technology transfer project. Similar to the other practices deployed prior, this practice
also facilitated rich dialogue amongst the team members, providing a process, a time and a
context to explore and exchange tacit knowledge. The perspective of this process was
prompting the team to ‘zoom out’ to the big picture with the PPQ batches completed. As the
questions in Figure 5 illustrate, they are intended to explore un-met expectations, sources of
uncertainty, concerns, and future opportunities. This practice enabled the receiving site to
engage in candid, transparent dialogue and to “learn after” completion of the technology
transfer activities.
Results
Similar to the What if…? process, the dialogue that emerged provided rich insights to inform
risk, training of staff and future process development opportunities. In this case, the team
identified 70 “answers” to the questions posed as part of the process. These 70 answers
resulted in 39 actions taken to close gaps. These gaps were grouped into key categories of:
•
•
•
•
•
•
•

Unexpected from PPQ (20%)
What keeps you up at night (20%)
Process improvement opportunities (17%)
Learnings to share from key failed experiments (12%)
Items that are least repeatable (8%)
‘Rules of thumb’ to capture (7%)
Other (areas to study more, things not understood from PPQ, rationale from past decisions)

This TKTA process was conducted in addition to a formal after-action review and generated
additional valuable insights and opportunities as it provided a different line of questioning
than a traditional AAR. A tracking mechanism with basic metrics and regular review with the
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technology transfer leadership team who provided appropriate governance were key
enablers.

5. Additional practices to facilitate tacit knowledge flow during technology
transfer

While this case study presents three practices focused exclusively on tacit knowledge for
technology transfer, the authors acknowledge there are several additional KM practices
which can be highly beneficial in facilitating tacit knowledge transfer. For each, a standard
process, supporting tools and templates, a mindset to manage knowledge as an asset and
appropriate governance are critical success factors. Table I below outlines a series of
additional KM practices which may be beneficial.
Table I - Additional KM practices for tacit knowledge
KM Practice

Retention of critical
knowledge

After-action review
(AAR)
Decision Trackers

Subject Matter
Expert (SME) Listing
Communities of
Practice (CoPs)

Description relative to technology transfer

The retention of critical knowledge process is a risk assessment and risk
management process to mitigate the impact of employee turnover, especially highly
experienced staff with unique, ‘mission critical’ knowledge. This process can be
applied during technology transfer (e.g. if experts leave the project or the
organization) and/or selectively at the end of the technology transfer before experts
move on to new assignments. The retention of critical knowledge process starts
with a risk assessment of the individual’s knowledge to help objectively define and
prioritize areas of highest risk (what knowledge is critical or unique to this
individual). Once prioritized topics are identified, the process guides the manager
and expert through a series of facets of expertise to evaluate including know-what,
know-how, know-who, and know-why. Knowledge transfer happens primarily during
dialogue between expert and (ideally) successor or other expert, and through new
knowledge assets created in response to the prioritized risks (e.g., white papers,
training modules, product histories or other critical knowledge).
After action review, and closely related KM practice of lessons learned, are wellcharacterized processes [22] which focuses on extracting lessons from projects or
events (what went well, in addition to what did not go well) and to ensure better
performance on future project through targeted process improvements.
Simple lists of key decisions with supporting rationale (e.g. assumptions, choices
evaluated, selection criteria and reasoning) can be beneficial to the receiving unit,
who would not typically have understanding or visibility to these details ‘looking
back’ in the future. This tacit knowledge can help with investigations, risk
management, and development opportunities at a minimum
Simple lists of who the subject matter experts are for a given product and process
can be a valuable resource for future reference.
Communities of practice are powerful venues to connect diverse sets of people with
areas of common interest. For technology transfer, a community focused on the
process of technology transfer itself can help support the effective execution of the
business process for technology transfer. Further, topic-specific communities (e.g.
platform technologies) can also be invaluable to support technology transfer,
especially when problems arise.
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6. Discussion

The three knowledge transfer practices described in the case study, taken in aggregate,
allowed the receiving site to “learn before, learn during and learn after” the technology
transfer project, benefiting both the technology transfer at hand, the future of the product at
the site, and future technology transfer projects. The sending site is also likely to benefit in
understanding their effectiveness at capturing and transferring knowledge, creating a
learning opportunity for future projects. This rich tacit knowledge sharing also enables the
receiving site to go beyond the routine “minimal viable knowledge” typically shared as part
of a technology transfer project. Currently, this knowledge sharing tends to be heavily biased
to explicit knowledge – and is especially so when faced with the schedule, cost, and resource
pressures of technology transfer projects. When an organization realizes the potential impact
of these tacit knowledge transfer practices on the overall technology transfer and long-term
manufacturability of the product, the benefit becomes obvious.
These processes share common success factors, including a standard process, open ended
questions to foster dialogue, basic governance, supporting mindsets and active engagement.
Exhibiting the mindsets and active engagement to share important tacit knowledge during
technology transfer also demonstrates a fundamental behaviour of ‘a culture of knowledge
excellence.’ A ‘culture of knowledge excellence’ (i.e. ‘knowledge culture’) emphasizes “A way
of organizational life that enables and motivates people to create, share and utilize
knowledge for the benefit and enduring success of the organization.” [23] This knowledge
culture is further characterized by the boundaryless flow of knowledge, a culture of inclusion,
a sense of curiosity, a growth mindset and a desire to capture, share and grow knowledge
across the organization [24]. As an example of the potential impact, a study in Harvard
Business Review reported that workers who take time to reflect perform more than 20%
better than those who do not pause to reflect [25].
There are limitations to these processes. These processes by no means guarantee a perfect
technology transfer and they do impact on the time of key staff to execute. Therefore, they
must be appropriately sponsored by management and applied in a “fit for purpose” manner
and at the right time. Resulting actions must be prioritized. The critical success factors
discussed cannot be overlooked (including governance). In addition, while these practices
focus on tacit knowledge transfer, one must not forget there are other activities required for
explicit knowledge transfer (and the need for further enhancement).

7. Conclusion

Significant strides can be made in tacit knowledge transfer during technology transfer as
described in this case study and participant feedback. These processes aren’t overly complex,
onerous, or mysterious. Rather they are about a basic commitment and discipline to create
a time, space, and context for people to engage in dialogue, facilitated by open-ended,
probative questions to surface knowledge.
This tacit knowledge also includes assumptions, insights, decision rationale or other
knowledge which may well be obvious to the experienced sending site or SME but are likely
not so obvious to the receiving site staff. As the saying goes, “You don’t know what you know
until you are asked a question.” These simple processes when embedded in routine work do
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just that: They provide a process for knowledge to flow, and through the case study
presented above, have demonstrated clear benefits to proactive risk mitigation, improved
quality and higher right first time PPQ batches. In addition, there are long term benefits
anticipated, including improved process robustness and increased knowledge available to
inform risk-based decision making. And while this case study indeed focused on a highly
complex scenario, there is likely no lack of opportunity on the horizon given the growth of
technology transfers and more complex products (including advanced therapies).
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